Clinical Trial Update: Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial comparing iguratimod plus methotrexate to leflunomide plus methotrexate in rheumatoid arthritis, sponsored by Jiangsu Simcere P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• Leflunomide (Leflunomide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN